Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
Open Access
- 11 June 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (9), 1392-1399
- https://doi.org/10.1038/sj.bjc.6690534
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.Journal of Clinical Oncology, 1998
- Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.Journal of Clinical Oncology, 1997
- Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.Journal of Clinical Oncology, 1997
- Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.Journal of Clinical Oncology, 1996
- Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.Journal of Clinical Oncology, 1994
- The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumoursBritish Journal of Urology, 1994
- High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.Journal of Clinical Oncology, 1994
- The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party.Journal of Clinical Oncology, 1992
- Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)Cancer, 1991
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987